c-MYC amplification and expression in astrocytic tumors

Acta Neuropathologica

Volumn 116, Issue 1, 2008, Pages 87-95

  Faria, Mário Henrique ^a   Khayat, André Salim ^b   Burbano, Rommel Rodríguez ^b   Rabenhorst, Silvia Helena ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Astrocytoma; c MYC; FISH; Glioblastoma; Immunohistochemistry

Indexed keywords

MYC PROTEIN;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CARCINOGENESIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR BIOPSY;

ASTROCYTOMA; BRAIN NEOPLASMS; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE;

EID: 47749130029     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-008-0368-0     Document Type: Article

References (47)

1. Bai MK, Costopoulos JS, Christoforidou BP, Papadimitriou CS (1994) Immunohistochemical detection of the c-myc oncogene product in normal, hyperplastic and carcinomatous endometrium. Oncology 51:314-319
2. Baker MJ, Brem S, Daniels S, Sherman B, Phuphanich S (2002) Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate. J Neurooncol 59:239-242
3. Bernard S, Eilers M (2006) Control of cell proliferation and growth by Myc proteins. Results Probl Cell Differ 42:329-342
4. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI (2005) Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 65:8679-8689
5. Broaddus WC, Chen ZJ, Prabhu SS, Loudon WG, Gillies GT, Phillips LL, Fillmore H (1997) Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells. Neurosurgery 41:908-915
6. Calcagno DQ, Leal MF, Seabra AD, Khayat AS, Chen ES, Demachki S, Assumpcao PP, Faria MH, Rabenhorst SH, Ferreira MV, de Arruda Cardoso Smith M, Burbano RR (2006) Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J Gastroenterol 12:6207-6211
7. Chattopadhyay P, Banerjee M, Sarkar C, Mathur M, Mohapatra AK, Sinha S (1995) Infrequent alteration of the c-myc gene in human glial tumours associated with increased numbers of c-myc positive cells. Oncogene 11:2711-2714
8. Chen J, Willingham T, Margraf LR, Schreiber-Agus N, DePinho RA, Nisen PD (1995) Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat Med 1:638-643
9. Collins VP (2007) Mechanisms of disease, genetic predictors of response to treatment in brain tumors. Nat Clin Pract Oncol 4:362-374
10. Eisenman RN (2001) Deconstructing myc. Genes Dev 15:2023-2030
11. Fabbro M, Henderson BR (2003) Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp Cell Res 282:59-69
12. Facchini LM, Penn LZ (1998) The molecular role of Myc in growth and transformation:rEcent discoveries lead to new insights. FASEB J 12:633-651
13. Faria MH, Goncalves BP, do Patrocinio RM, de Moraes-Filho MO, Rabenhorst SH (2006) Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: Correlation with the histopathological grade and proliferative status. Neuropathology 26:519-527
14. Gonçalves BP, Faria MH, Moraes-Filho MO, Rabenhorst SH (2006) c-MYC expression is an alternative leading pathway to p53 mutation and EGFR overexpression in astrocytoma tumorigenesis: An immunohistochemical study. In: Eleventh Annual Meeting of the Society for Neuro-Oncology. Duke University Press, Orlando (USA). Neuro Oncol 8:458
15. Hann SR (2006) Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin Cancer Biol 16:288-302
16. Hayashi S, Yamamoto M, Ueno Y, Ikeda K, Ohshima K, Soma G, Fukushima T (2001) Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas. Neurol Med Chir (Tokyo) 41:187-195
17. Herms JW, von Loewenich FD, Behnke J, Markakis E, Kretzschmar HA (1999) c-myc oncogene family expression in glioblastoma and survival. Surg Neurol 51:536-542
18. Hosoi H, Dilling MB, Liu LN, Danks MK, Shikata T, Sekulic A, Abraham RT, Lawrence JC Jr, Houghton PJ (1998) Studies on the mechanism of resistance to rapamycin in human cancer cells. Mol Pharmacol 54:815-824
19. Huang H, Colella S, Kurrer M, Yonekawa Y, Kleihues P, Ohgaki H (2000) Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res 60:6868-6874
20. Jensen NA, Pedersen KM, Lihme F, Rask L, Nielsen JV, Rasmussen TE, Mitchelmore C (2003) Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas. J Biol Chem 278:8300-8308
21. Knoepfler PS (2007) Myc goes global, new tricks for an old oncogene. Cancer Res 67:5061-5063
22. Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA (2002) Comparative genomic hybridization in glioma: A meta-analysis of 509 cases. Cancer Genet Cytogenet 135:147-159
23. Lang FF, Miller DC, Koslow M, Newcomb EW (1994) Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81:427-436
24. Lassman AB, Dai C, Fuller GN, Vickers AJ, Holland EC (2004) Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. Neuron Glia Biol 1:157-163
25. Louis DN, Pomeroy SL, Cairncross JG (2002) Focus on central nervous system neoplasia. Cancer Cell 1:125-128
26. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 114:97-109
27. Lutz W, Leon J, Eilers M (2002) Contributions of Myc to tumorigenesis. Biochim Biophys Acta 1602:61-71
28. McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KS Sr (1985) Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109:716-721
29. Mohapatra G, Bollen AW, Kim DH, Lamborn K, Moore DH, Prados MD, Feuerstein BG (1998) Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade. Genes Chromosomes Cancer 21:195-206
30. Muleris M, Almeida A, Dutrillaux AM, Pruchon E, Vega F, Delattre JY, Poisson M, Malfoy B, Dutrillaux B (1994) Oncogene amplification in human gliomas: A molecular cytogenetic analysis. Oncogene 9:2717-2722
31. Nakamura M, Shimada K, Ishida E, Nakase H, Konishi N (2007) Genetic analysis to complement histopathological diagnosis of brain tumors. Histol Histopathol 22:327-335
32. Nishizaki T, Ozaki S, Harada K, Ito H, Arai H, Beppu T, Sasaki K (1998) Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosomes Cancer 21:340-346
33. Orian JM, Vasilopoulos K, Yoshida S, Kaye AH, Chow CW, Gonzales MF (1992) Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer 66:106-112
34. Pelengaris S, Khan M, Evan G (2002) c-MYC: More than just a matter of life and death. Nat Rev Cancer 2:764-776
35. Reifenberger G, Collins VP (2004) Pathology and molecular genetics of astrocytic gliomas. J Mol Med 82:656-670
36. Ried T, Heselmeyer-Haddad K, Blegen H, Schröck E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation. Genes Chromosomes Cancer 25:195-204
37. Royds JA, Sharrard RM, Wagner B, Polacarz SV (1992) Cellular localisation of c-myc product in human colorectal epithelial neoplasia. J Pathol 166:225-233
38. Sasano H, Nagura H, Silverberg SG (1992) Immunolocalization of c-myc oncoprotein in mucinous and serous adenocarcinomas of the ovary. Hum Pathol 23:491-495
39. Satoh M, Sashima M, Hatakeyama S, Yoshimura N, Otsu T, Suzuki A (1992) Immunohistochemical localization of c-myc oncogene product in oral papilloma. J Oral Pathol Med 21:97-99
40. Sears RC, Nevins JR (2002) Signaling networks that link cell proliferation and cell fate. J Biol Chem 277:11617-11620
41. Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, Vogelstein B (1986) Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83:470-473
42. Vervoorts J, Luscher-Firzlaff J, Luscher B (2006) The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem 281:34725-34729
43. Vita M, Henriksson M (2006) The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16:318-330
44. Wade M, Wahl GM (2006) c-Myc, genome instability, and tumorigenesis: The devil is in the details. Curr Top Microbiol Immunol 302:169-203
45. Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G, Kiessling M, Cremer T (1996) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13:983-994
46. Williams AR, Piris J, Wyllie AH (1990) Immunohistochemical demonstration of altered intracellular localization of the c-Myc oncogene product in human colorectal neoplasms. J Pathol 160:287-293
47. Yamamoto T, Yasui W, Ochiai A, Ito H, Abe K, Yanaihara N, Tahara E (1987) Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: Expression in tumor cells and stromal cells. Jpn J Cancer Res 78:1169-1174